老年利尿剂治疗患者中严重甲氨蝶呤毒性
该研究分析了因低剂量甲氨蝶呤(MTX)严重毒性入住风湿科病房的12例患者,并与168例年龄>70岁、使用MTX但无毒性表现的患者对比。结果显示,毒性组在急性事件前常规就诊时中位eGFR更低(64 vs 69 mL/min×1.73,p=0.0251),且更常使用利尿剂(6/12 vs 24/168)、质子泵抑制剂(PPIs;10/12 vs 70/168)和左乙拉西坦(2/12 vs 1/168)。作者认为年龄>70岁、eGFR较低及使用利尿剂、PPIs和左乙拉西坦的患者MTX毒性风险显著更高。
要点
- 12例因MTX毒性入院患者均>70岁,其中1例死于感染,11例经亚叶酸钙治疗存活。
- 毒性组急性事件前中位eGFR为64(范围32-77)mL/min×1.73,低于无毒性MTX组的69(范围8至>90),p=0.0251。
- 多因素分析显示毒性组更常用利尿剂(6/12 vs 24/168)、PPIs(10/12 vs 70/168)和左乙拉西坦(2/12 vs 1/168)。
核心结论
- 年龄>70岁且eGFR较低、使用利尿剂、PPIs或左乙拉西坦的患者发生MTX毒性的风险显著更高。
研究设计与样本
- 分析所有因严重低剂量MTX毒性入住风湿科病房患者的临床表现、病程和危险因素,并与无相关MTX毒性表现的患者进行比较。
- 12例因MTX毒性入院患者中,7例类风湿关节炎、2例银屑病关节炎或银屑病、2例巨细胞动脉炎、1例肌炎。
- 12例毒性患者均>70岁,与400例>70岁但无MTX毒性的患者比较;其中未用MTX组232例,用MTX组168例。
主要发现
- 12例毒性患者中1例死于感染,11例在亚叶酸钙给药下存活。
- 400例对照中,未用MTX组(n=232)肾功能损害多于用MTX组(n=168)。
- 与168例无毒性MTX治疗患者相比,12例危及生命毒性事件患者急性事件前常规就诊时中位eGFR更低:64(范围32-77) vs 69(范围8至>90)mL/min×1.73,p=0.0251。
关键数值与推荐
- 多因素分析发现毒性患者更常使用利尿剂(6/12 vs 24/168)、质子泵抑制剂(PPIs;10/12 vs 70/168)和左乙拉西坦(2/12 vs 1/168)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To explore the toxicity of low-dose methotrexate (MTX), an uncommon, but life-threatening event. METHODS: We analysed the presentation, course and risk factors of all patients admitted to the rheumatology ward with severe low-dose MTX toxicity. These patients were compared with patients without signs of relevant MTX toxicity. RESULTS: The 12 patients admitted for MTX toxicity included 7 patients with rheumatoid arthritis, 2 with psoriatic arthritis or psoriasis, 2 patients with giant cell arteritis and 1 with myositis. 1 patient died from infections, while 11 survived under folinic acid administration. All patients suffering from severe MTX toxicity were older than 70 years and were therefore compared with 400 patients who were also older than 70 years, but without MTX toxicity. Of these 400 control patients, the group of patients not on MTX (n=232) had more renal impairment than the group of patients on MTX (n=168). Compared with the 168 MTX-treated patients without toxicity, the 12 patients with life-threatening toxic events had a lower median estimated glomerular filtration rate (eGFR) at the routine visit preceding the acute event (64 (range 32-77) vs 69 (range 8 to >90) mL/min x 1.73, p=0.0251). A multivariate analysis found that patients with toxicity were more frequently treated with diuretics (6/12 vs 24/168), proton pump inhibitors (PPIs; 10/12 vs 70/168) and levetiracetam (2/12 vs 1/168). CONCLUSIONS: Patients older than 70 years with lower eGFR and being on diuretics, but also on PPIs and levetiracetam, have a significantly higher risk for MTX toxicity.
引用
- Kumar C, Kuhn M, Herrmann K, et al. Severe methotrexate toxicity in elderly patients under diuretics. RMD Open. 2024. PMID: 38176739. doi:10.1136/rmdopen-2023-003827
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。